Skip to main content

Aliskiren News

Noden Pharma Announces FDA Approval of Tekturna (aliskiren) Oral Pellets for the Treatment of Hypertension in Adults and Children 6 Years of Age and Older

DUBLIN, Nov. 15, 2017 /PRNewswire/ – Noden Pharma DAC, a global specialty pharmaceutical company that is focused on acquiring prescription medicines across a broad range of therapeutic areas,...

FDA Medwatch Alert: Aliskiren-containing Medications: Drug Safety Comunication - New Warning and Contraindication

including: Amturnide (aliskiren hemifumarate, amlodipine besylate, and hydrochlorothiazide) Tekturna (aliskiren hemifumarate) Tekturna HCT (aliskiren hemifumarate and hydrochlorothiazide) Tekamlo...

Novartis Gains FDA Approval for Amturnide, a Triple-Combination Pill to Treat High Blood Pressure in Patients Uncontrolled on Two Medications

EAST HANOVER, N.J., December 22, 2010, 2010 /PRNewswire/ – Today Novartis announced that the US Food and Drug Administration (FDA) approved Amturnide (aliskiren, amlodipine and hydrochlorothiazide)...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

High Blood Pressure, Hypertension

Aliskiren patient information at Drugs.com